Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure

Thorax. 2019 Nov;74(11):1099-1101. doi: 10.1136/thoraxjnl-2019-213621. Epub 2019 Sep 18.

Abstract

Muscle mitochondrial dysfunction is implicated in intensive care unit-acquired weakness, but there is no serum biomarker of muscle mitochondrial function for critical illness survivors. Higher serum growth differentiation factor-15 (GDF-15) is a biomarker of inherited mitochondrial myopathy disease and is associated with mortality in several age-related diseases. Among 142 older (age ≥ 65 years) survivors of acute respiratory failure, we found that higher serum GDF-15 measured during the week prior to hospital discharge was cross-sectionally associated with weaker diaphragm, limb and hand-grip strength, and longitudinally associated with lower rates of functional recovery over 6 months, independent of age, sex, pre-existing disability, comorbidity, frailty, Acute Physiology and Chronic Health Evaluation II scores and concurrent interleukin-6 levels.

Keywords: Critical Care; Not Applicable; Pulmonary Rehabilitation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Diaphragm / physiopathology*
  • Female
  • Growth Differentiation Factor 15 / blood*
  • Hand Strength*
  • Humans
  • Male
  • Middle Aged
  • Recovery of Function
  • Respiratory Insufficiency / blood*
  • Respiratory Insufficiency / physiopathology
  • Survivors

Substances

  • Biomarkers
  • GDF15 protein, human
  • Growth Differentiation Factor 15